Eastern Mediterranean (WHO region) vs Niger: Hepatitis B surface antigen (HBsAg) prevalence (%)
Eastern Mediterranean (WHO region)
0.5%
in 2024
Niger
3.2%
in 2024
Eastern Mediterranean (WHO region) rank
4th
Niger rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Eastern Mediterranean (WHO region)
- Niger
How they compare
Niger currently reports 3.2% against 0.5% in Eastern Mediterranean (WHO region), a difference of 2.7%.
That makes Niger's figure about 6.4 times Eastern Mediterranean (WHO region)'s.
Across all 10 years both countries report, Niger has been ahead every year.
Eastern Mediterranean (WHO region) ranks 4th and Niger ranks 3rd of 13 groups.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 2.6% | 2.1% | Niger |
| 2020s | 0.5% | 3.4% | 2.9% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Eastern Mediterranean (WHO region) or Niger?
- Niger, at 3.2% against 0.5% in Eastern Mediterranean (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Eastern Mediterranean (WHO region) and Niger?
- 2.7%, with Niger ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Eastern Mediterranean (WHO region) and Niger rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Eastern Mediterranean (WHO region) ranks 4th and Niger ranks 3rd of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.